Larson Financial Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$136K Buy
605
+155
+34% +$38.6K ﹤0.01% 860
2025
Q4
$108K Buy
450
+182
+68% +$46.5K ﹤0.01% 910
2025
Q3
$73.4K Buy
268
+15
+6% +$4.1K ﹤0.01% 1019
2025
Q2
$65.3K Sell
253
-55
-18% -$13.1K ﹤0.01% 974
2025
Q1
$69K Buy
308
+278
+927% +$64.9K ﹤0.01% 900
2024
Q4
$6.86K Sell
30
-36
-55% -$8.67K ﹤0.01% 1589
2024
Q3
$16.1K Buy
66
+62
+1,550% +$13.9K ﹤0.01% 1295
2024
Q2
$766 Hold
4
﹤0.01% 1759
2024
Q1
$792 Hold
4
﹤0.01% 1489
2023
Q4
$688 Buy
+4
New +$615 ﹤0.01% 1531
2023
Q1
Sell
-25
Closed -$5.2K 1595
2022
Q4
$5.2K Buy
+25
New +$5.49K ﹤0.01% 1017

Other funds holding RMD

Larson Financial Group's RMD Position: Q1 2026 in Review

Larson Financial Group increased its ResMed (RMD) stake by 34% in Q1 2026, buying an estimated $38.6K and bringing the position to 605 shares worth $136K. The position accounts for ﹤0.01% of the portfolio, ranked #860.

Larson Financial Group first reported a position in RMD in Q4 2022 and has held it in 11 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Larson Financial Group held 605 shares of ResMed worth $136K as of Q1 2026.
  • Larson Financial Group bought 155 ResMed shares in Q1 2026, an estimated $38.6K.
  • ResMed made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #860 holding.
  • Larson Financial Group first reported a position in ResMed in Q4 2022 and has held it in 11 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.